Found: 8
Select item for more details and to access through your institution.
Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1502, doi. 10.3390/ijms22031502
- By:
- Publication type:
- Article
Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
- Published in:
- Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02531-1
- By:
- Publication type:
- Article
Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2018, v. 197, n. 3, p. 373, doi. 10.1164/rccm.201703-0502OC
- By:
- Publication type:
- Article
Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”.
- Published in:
- BioMed Research International, 2018, p. 1, doi. 10.1155/2018/7491284
- By:
- Publication type:
- Article
Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/3293584
- By:
- Publication type:
- Article
Effect of p53 activation on experimental right ventricular hypertrophy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 6, p. 1, doi. 10.1371/journal.pone.0234872
- By:
- Publication type:
- Article